Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. markets closed

S&P Futures
6,013.50
+26.50(+0.44%)
Dow Futures
44,651.00
+256.00(+0.58%)
Nasdaq Futures
20,955.25
+105.50(+0.51%)
Russell 2000 Futures
2,439.10
+25.50(+1.06%)
Crude Oil
70.97
-0.27(-0.38%)
Gold
2,701.90
-10.30(-0.38%)

Bolt Biotherapeutics, Inc. (BOLT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

0.5786

+0.0141

(+2.50%)

At close: 04:00PM EST

0.5700

-0.01

(-1.49%)

After hours:

07:34PM EST

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	22.14M
Enterprise Value	-13.48M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	2.25
Price/Book (mrq)	0.31
Enterprise Value/Revenue	-18.31
Enterprise Value/EBITDA	0.93

Trading Information

Stock Price History

Beta (5Y Monthly)	0.92
52-Week Change ³	-37.74%
S&P500 52-Week Change ³	31.18%
52 Week High ³	1.5600
52 Week Low ³	0.5400
50-Day Moving Average ³	0.6308
200-Day Moving Average ³	0.8568

Share Statistics

Avg Vol (3 month) ³	137.05k
Avg Vol (10 day) ³	125.56k
Shares Outstanding ⁵	38.27M
Implied Shares Outstanding ⁶	38.27M
Float ⁸	25.04M
% Held by Insiders ¹	3.46%
% Held by Institutions ¹	58.19%
Shares Short (Oct 31, 2024) ⁴	65.99k
Short Ratio (Oct 31, 2024) ⁴	0.54
Short % of Float (Oct 31, 2024) ⁴	0.22%
Short % of Shares Outstanding (Oct 31, 2024) ⁴	0.17%
Shares Short (prior month Sep 30, 2024) ⁴	119.13k

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	-1,492.71%

Management Effectiveness

Return on Assets (ttm)	-29.41%
Return on Equity (ttm)	-58.04%

Income Statement

Revenue (ttm)	11.17M
Revenue Per Share (ttm)	0.29
Quarterly Revenue Growth (yoy)	-11.00%
Gross Profit (ttm)	N/A
EBITDA	-72.23M
Net Income Avi to Common (ttm)	-66.17M
Diluted EPS (ttm)	-1.7100
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	73.7M
Total Cash Per Share (mrq)	1.93
Total Debt (mrq)	18.89M
Total Debt/Equity (mrq)	22.00%
Current Ratio (mrq)	4.28
Book Value Per Share (mrq)	2.96

Cash Flow Statement

Operating Cash Flow (ttm)	-63.91M
Levered Free Cash Flow (ttm)	-33.36M